ALCHEMIST LIMITED | SURYA PHARMA | ALCHEMIST LIMITED/ SURYA PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -0.0 | 0.0 | - | View Chart |
P/BV | x | - | - | - | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
ALCHEMIST LIMITED SURYA PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
ALCHEMIST LIMITED Mar-20 |
SURYA PHARMA Mar-13 |
ALCHEMIST LIMITED/ SURYA PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 2 | 12 | 15.9% | |
Low | Rs | 1 | 1 | 53.0% | |
Sales per share (Unadj.) | Rs | 10.6 | 3.5 | 306.0% | |
Earnings per share (Unadj.) | Rs | -34.5 | -13.4 | 257.0% | |
Cash flow per share (Unadj.) | Rs | -29.6 | -10.7 | 277.4% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | -144.7 | -3.3 | 4,445.3% | |
Shares outstanding (eoy) | m | 13.56 | 248.05 | 5.5% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.1 | 1.9 | 6.2% | |
Avg P/E ratio | x | 0 | -0.5 | 7.4% | |
P/CF ratio (eoy) | x | 0 | -0.6 | 6.9% | |
Price / Book Value ratio | x | 0 | -2.1 | 0.4% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 17 | 1,656 | 1.0% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 54 | 139 | 38.8% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 144 | 862 | 16.7% | |
Other income | Rs m | 3 | 10 | 30.1% | |
Total revenues | Rs m | 147 | 871 | 16.9% | |
Gross profit | Rs m | -511 | -2,006 | 25.5% | |
Depreciation | Rs m | 66 | 683 | 9.7% | |
Interest | Rs m | 6 | 2,216 | 0.2% | |
Profit before tax | Rs m | -580 | -4,896 | 11.8% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | -113 | -1,569 | 7.2% | |
Profit after tax | Rs m | -467 | -3,327 | 14.0% | |
Gross profit margin | % | -354.4 | -232.8 | 152.2% | |
Effective tax rate | % | 19.4 | 32.0 | 60.6% | |
Net profit margin | % | -324.2 | -386.1 | 84.0% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 3,914 | 9,911 | 39.5% | |
Current liabilities | Rs m | 1,612 | 18,404 | 8.8% | |
Net working cap to sales | % | 1,597.5 | -985.7 | -162.1% | |
Current ratio | x | 2.4 | 0.5 | 450.9% | |
Inventory Days | Days | 4,698 | 667 | 704.7% | |
Debtors Days | Days | 95,960 | 956,724,304 | 0.0% | |
Net fixed assets | Rs m | 3,258 | 9,029 | 36.1% | |
Share capital | Rs m | 136 | 248 | 54.7% | |
"Free" reserves | Rs m | -2,097 | -1,055 | 198.7% | |
Net worth | Rs m | -1,962 | -807 | 243.0% | |
Long term debt | Rs m | 7,629 | 3,841 | 198.6% | |
Total assets | Rs m | 7,172 | 18,941 | 37.9% | |
Interest coverage | x | -103.9 | -1.2 | 8,588.6% | |
Debt to equity ratio | x | -3.9 | -4.8 | 81.7% | |
Sales to assets ratio | x | 0 | 0 | 44.2% | |
Return on assets | % | -6.4 | -5.9 | 109.8% | |
Return on equity | % | 23.8 | 412.1 | 5.8% | |
Return on capital | % | -10.1 | -88.3 | 11.5% | |
Exports to sales | % | 0 | 24.2 | 0.0% | |
Imports to sales | % | 0 | 0.6 | 0.0% | |
Exports (fob) | Rs m | NA | 209 | 0.0% | |
Imports (cif) | Rs m | NA | 5 | 0.0% | |
Fx inflow | Rs m | 0 | 209 | 0.0% | |
Fx outflow | Rs m | 0 | 9 | 0.0% | |
Net fx | Rs m | 0 | 199 | 0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -40 | 1,332 | -3.0% | |
From Investments | Rs m | -1 | -79 | 1.6% | |
From Financial Activity | Rs m | 45 | -1,331 | -3.4% | |
Net Cashflow | Rs m | 4 | -79 | -5.6% |
Indian Promoters | % | 34.8 | 1.0 | 3,625.0% | |
Foreign collaborators | % | 0.2 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.5 | 0.0 | 7,550.0% | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 65.1 | 99.0 | 65.7% | |
Shareholders | 10,223 | 24,606 | 41.5% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare ALCHEMIST LIMITED With: DIVIS LABORATORIES SUN PHARMA CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | ALCHEMIST LIMITED | SURYA PHARMA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 4.88% | -5.88% | 1.23% |
1-Month | 4.88% | -15.79% | -0.24% |
1-Year | -71.63% | -87.69% | 43.62% |
3-Year CAGR | 18.04% | -55.45% | 20.35% |
5-Year CAGR | -34.46% | -38.44% | 26.24% |
* Compound Annual Growth Rate
Here are more details on the ALCHEMIST LIMITED share price and the SURYA PHARMA share price.
Moving on to shareholding structures...
The promoters of ALCHEMIST LIMITED hold a 35.0% stake in the company. In case of SURYA PHARMA the stake stands at 1.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALCHEMIST LIMITED and the shareholding pattern of SURYA PHARMA.
Finally, a word on dividends...
In the most recent financial year, ALCHEMIST LIMITED paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
SURYA PHARMA paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of ALCHEMIST LIMITED, and the dividend history of SURYA PHARMA.
For a sector overview, read our pharmaceuticals sector report.
After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.